VentriPoint Diagnostics Ltd.
VPTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15,707 | $47,377 | $40,262 | $48,170 |
| - Cash | $61 | $1,294 | $5,186 | $9,269 |
| + Debt | $1,635 | $412 | $459 | $160 |
| Enterprise Value | $17,281 | $46,495 | $35,536 | $39,061 |
| Revenue | $95 | $49 | $68 | $0 |
| % Growth | 93.5% | -27.8% | – | – |
| Gross Profit | $95 | $42 | $58 | -$49 |
| % Margin | 100% | 86.3% | 84.8% | – |
| EBITDA | -$4,760 | -$4,747 | -$4,794 | -$3,702 |
| % Margin | -5,002% | -9,651.4% | -7,032.3% | – |
| Net Income | -$4,920 | -$4,872 | -$4,873 | -$3,881 |
| % Margin | -5,169.1% | -9,905.7% | -7,148.3% | – |
| EPS Diluted | -0.031 | -0.031 | -0.031 | -0.029 |
| % Growth | 0% | 0.3% | -9.5% | – |
| Operating Cash Flow | -$3,386 | -$3,804 | -$4,137 | -$3,147 |
| Capital Expenditures | $0 | $0 | $0 | -$4 |
| Free Cash Flow | -$3,386 | -$3,804 | -$4,137 | -$3,151 |